Expert Insights into Optimal Outpatient Management of Acute and Long COVID-19

During IDWeek 2022, join this 2-hour satellite symposium that will feature presentations and a panel discussion of questions about COVID-19 in the outpatient setting. The topic areas covered will include patient assessment, outpatient treatment, and post-COVID conditions.

This is an affiliated event (not official IDWeek programming).


  • Welcome and Baseline Polling (5 minutes)
  • Patient Assessment: Testing, Diagnosis, and Risk Stratification (35 minutes)
  • Treatment: Management of Acute COVID-19 in Nonhospitalized Patients (35 minutes)
  • Post-COVID Conditions: Current and Future Directions (30 minutes)
  • Audience Question and Answer Session (15 minutes)


Date / Time
Event Details


Program Director
Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Fernando Carnavali, MD

Rasika Karnik, MS, MD

Assistant Professor
Division of Primary Care
Department of Internal Medicine
University of Chicago
Medical Director
Post-COVID Recovery Clinic
Chicago, Illinois

Joseph Torrisi, PharmD

Program Overview
This program is designed to overcome gaps in the outpatient management of acute COVID and in understanding the evolving science and best practices in management of post-COVID conditions.

Goal Statement
To improve healthcare professionals’ (HCPs) competence in optimizing outpatient management of COVID-19, including timely diagnosis, risk stratification, and treatment, and to expand HCPs’ ability to apply emerging data on the epidemiology, presentation, and emerging data regarding prevention and management of post-COVID conditions.

Target Audience
This program is intended for physicians, pharmacists, and other HCPs involved in the management of nonhospitalized patients with current or previous COVID-19, including both specialists and primary care providers. This identified target audience will benefit from this education by gaining the knowledge and strategies necessary to individualize outpatient management of acute COVID and post-COVID conditions.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Implement strategies to ensure equitable and timely COVID-19 testing and diagnosis
  • Utilize best practices for risk stratification of nonhospitalized patients with COVID-19 to determine eligibility for outpatient treatment
  • Develop individualized care plans for outpatients diagnosed with SARS-CoV-2 infection based on guideline recommendations, current clinical data, and potential logistical or supply constraints
  • Apply approaches to preventing and managing post-COVID conditions based on emerging data and current best practices


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

CCO designates this continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-226-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.